Messung der Hautdicke mittels Hochfrequenzultraschall zur Objektivierung einer Hormonersatztherapie in der Perimenopause

Zusammenfassung

Studienziel: Die Studie hatte zum Ziel, die Hautdickenveränderungen, beeinflusst durch drei verschiedene Hormonersatztherapien (HRT), zu vergleichen. Methode: Die Hautdicke wurde mittels einer Hochfrequenz-Ultraschall-Technik bei perimenopausalen Frauen mit erniedrigtem Östradiol (< 45 pg/ml) an der Innenseite des linken Oberarmes bestimmt. Die Patientinnen wurden in Gruppen zusammengefasst: Gruppe 1 (n = 6) erhielt nur Östradiol transdermal; Gruppe 2 (n = 7) Östradiol transdermal und Progesteron vaginal; Gruppe 3 (n = 8) Östradiol oral und Progesteron vaginal; Gruppe 4 (n = 3) bildete die Kontrollgruppe ohne Therapie. Ergebnisse: Der Medianwert der Hautdicke von allen HRT-Gruppen zeigte eine hoch signifikante Zunahme von 0,15 mm nach sechs Monaten (0,91 mm vor Therapie versus 1,06 mm nach sechs Monaten HRT). Im Gegensatz zeigte sich bei der Kontrollgruppe kein signifikanter Unterschied. Schlussfolgerung: Die Studie zeigt, dass eine HRT zu einer Hautdickenzunahme führt, die mittels hochauflösendem Ultraschall gemessen werden kann.

Measurement of Skin Thickness by High-frequency Ultrasound to Objectify the Effects of Hormone Replacement Therapy in the Perimenopause

Aim: The aim of this study was to show the influence of three different hormone replacement therapy regimes (HRT) by comparing the changes in skin thickness. Method: Skin thickness was measured using a high-frequency ultrasound system on the inner side of the left upper arm of perimenopausal women with a low oestradiol level (< 45 pg/ml). The patients were allocated to different groups: Group1 (n = 6) received oestradiol merely transdermally; Group 2 (n = 7) was given transdermal oestradiol as well as progesterone vaginally; Group 3 (n = 8) took oral oestradiol and vaginal progesterone; Group 4 (n = 3) served as the control group without therapy. Results: The median value of skin thickness in all HRT-groups increased highly significantly (0.15 mm) after six months (0.91 mm before therapy versus 1.06 mm after six months of HRT), but there was no significant change in the control group. Conclusions: The study shows that HRT leads to an increase of skin thickness which can be demonstrated by a high-frequency ultrasound.

Hautalterung - Hautdicke - Hormonersatztherapie - Hochfrequenzultraschall

Skin ageing - Skin thickness - Hormone replacement therapy - High-frequency ultrasound

Literatur

• 1 Marks R, Edwards C. The measurement of photodamage.  Br J Dermatol. 1992;  127 (Suppl 41) 7-13
• 2 Gilchrest B A, Yaar M. Ageing and photoageing of the skin: observations at the cellular and molecular level.  Br J Dermatol. 1992;  127 25-30
• 3 Castelo-Branco C, Duran M, Gonzalez-Merlo J. Skin collagen changes related to age and hormone replacement therapy.  Maturitas. 1992;  15 113-119
• 4 Epstein E H, Munderloh N H. Isolation and characterization of CNBr peptides of human (α 1 [III])₃ collagen and tissue distribution of (α 1 [III])₃ collagens.  J Biol Chem. 1975;  250 9304-9312
• 5 Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette G. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimes on the skin of postmenopausal women using non-invasive measurement techniques.  Dermatology. 1996;  193 289-294
• 6 Shuster S, Black M M, McVitie E. The influence of age and sex on skin thickness, skin collagen and density.  Br J Dermatol. 1975;  93 639-643
• 7 Serup J. Ten years experience with highfrequency ultrasound examination of the skin. In: Altmeyer P, el-Gammal S, Hoffmann K (Eds) Ultrasound in Dermatology. Berlin; Springer 1992: 41-54
• 8 Gruber D M, Sator M O, Frigo P, Knogler W, Huber J C. Messung der Hautdicke bei perimenopausalen Frauen - Korrelation mit Knochendichte und Hormonparametern.  Ultraschall in Med. 1995;  16 22-24
• 9 Kreitz G. A- and B-Scan techniques of conventional ultrasound units. A survey. In: Altmeyer P, el-Gammal S, Hoffmann K (Eds) Ultrasound in Dermatology. Berlin; Springer 1992: 12-21
• 10 Tan C Y, Statham B, Marks R, Payne P A. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability.  Br J Dermatol. 1982;  106 657-667
• 11 Aekesson A, Forsberg L, Hedeström N, Wollheim F. Ultrasound examination of skin thickness in patients with progressive systemic sclerosis (scleroderma).  Acta Radiol Diagn. 1986;  27 91-94
• 12 Myers S L, Cohen J S, Sheets P W. B-mode ultrasound evaluation of skin thickness in progressive systemic sclerosis.  J Rheumatol. 1986;  13 577-580
• 13 Ulrich J, Petereit S, Gollnick H. Präoperative sonographische Melanomdiagnostik - Vergleich von 7,5- und 20-MHz-Sonographie.  Ultraschall in Med. 1999;  20 197-200
• 14 Vaillant L, Berson M, Machet L, Callens A, Pourcelot L, Lorette G. Ultrasound imaging of psoriatic skin: a noninvasive technique to evaluate treatment of psoriasis.  Int J Dermatol. 1994;  33 786-790
• 15 Schmidt J B, Binder M, Macheiner W, Kainz C, Gitsch G, Bieglmayer C. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study.  Maturitas. 1994;  20 25-30
• 16 Dunn L B, Damesyn M, Moore A A, Reuben D B, Greendale G A. Does estrogen prevent skin aging? Results from the first national health and nutrition examination survey (NHANES I).  Arch Dermatol. 1997;  133 339-342
• 17 Pierard G E. The quandary of climacteric skin ageing.  Dermatology. 1996;  193 273-274
• 18 Pierard G E, Letawe C, Dowlati A, Pierard-Franchimont C. Effect of hormone replacement therapy for menopause on the mechanical properties of skin.  J Am Geriatr Soc. 1995;  43 662-665
• 19 Punnonen R, Rauramo L. Effect of estrogen therapy on climacteric symptoms and tissue changes.  Acta Obstet Gynec Scand. 1974;  53 267-269
• 20 Brincat M, Moniz C J, Studd J WW, Darby A, Magos A, Emburey G, Versi E. Long-term effects of the menopause and sex hormones on skin thickness.  Br J Obstet Gynaecol. 1985;  92 256-259
• 21 Creidi P, Faivre B, Agache P, Richard E, Haudiquet V, Sauvant J P. Effect of a conjugated oestrogen (Premarin®) cream on ageing facial skin. A comparative study with a placebo cream.  Maturitas. 1994;  19 211-223
• 22 Punnonen R, Viska S, Rauramo L. Skinfold thickness and long-term postmenopausal hormone therapy.  Maturitas. 1984;  5 259-262
• 23 Haapasaari K M, Raudaskoski T, Kallioinen M, Sutvanto-Luukkonen E, Kauppila A, Läärä E, Risteli J, Oikarinen A. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women.  Maturitas. 1997;  27 153-162
• 24 Eisenbeiss C, Welzel J, Schmeller W. The influence of female sex hormones on skin thickness: evaluation using 20-MHz sonography.  Br J Dermatol. 1998;  139 462-467